Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

摘要: Background: National data from the mid-1990s demonstrated that many eligible patients did not receive highly active antiretroviral therapy (HAART) and racial gender disparities existed in HAART receipt. We examined whether demographic use of persist 2001 if outpatient care is associated with utilization. Methods: Demographic, clinical, pharmacy utilization were collected 10 US HIV primary sites Research Network (HIVRN). Using multivariate logistic regression, we clinical differences receipt association HAART. Results: In our cohort 2001, 84% received 66% had 4 or more visits during calendar year (CY) 2001. Of those 2 CD4 counts below 350 cells/mm 3 91% HAART; 82% 1 test result 77% no Adjusting for site analyses, age >40 years (adjusted odds ratio [AOR] = 1.13), male (AOR 1.23), Medicaid coverage 1.16), Medicare 1.73), having less than 1.33), a (OR 1.34) significantly an increased likelihood African Americans (odds [OR] 0.84) injection drug risk factor 0.86) likely to Conclusions: Although overall prevalence has since mid-1990s, persist. Our results support attempts increase access frequency underutilizing groups as well efforts reduce persistent women, Americans, users (IDUs).